Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Nucleoside. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover the patented one-pot synthesis of 5'-chloronucleosides using PPh3 and hexachloroethane. A reliable pharmaceutical intermediates supplier offering high purity and cost-effective manufacturing solutions.
Patent CN110981863A details a novel route for Sofosbuvir intermediates using unique imidate donors, offering superior beta-selectivity and streamlined purification for API manufacturing.
Novel enzymatic route for 2'-O-propynyl-guanosine. Higher yield, simplified process for oligonucleotide manufacturing supply chain.
Patent CN107698590A details asymmetric cyclization for high-purity nucleosides. Offers cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN1380299A reveals a crystallization method replacing column chromatography for purifying nucleoside intermediates, offering significant cost and scalability advantages.
Novel gold-catalyzed route ensures safe scalable production of high-purity nucleoside analogs with significant cost and supply chain advantages for pharmaceutical partners.
Patent CN1022688C discloses novel 5'-deoxy-5-fluorocytidine derivatives with reduced toxicity. Discover cost-effective manufacturing and supply chain solutions for high-purity API intermediates.
Patent CN101200463B details a cost-effective D-glucose route for 4-thio-D-ribose intermediates, offering significant supply chain advantages over traditional L-lyxose methods.
Novel route from D-glucose reduces cost for 4-thio-nucleoside intermediates. High purity scalable process for antiviral drug synthesis.
Patent CN118852303A details a novel aminolysis method for cytidine vinyl phosphate, offering high purity and cost reduction in nucleoside manufacturing for global supply chains.
Patent CN113754694B reveals a novel chiral bicyclic imidazole catalyst method for Remdesivir. Achieve high-purity API intermediates with reduced manufacturing costs.
Patent CN102617677A details a high-yield route for Gemcitabine HCl using Reformatsky reaction, offering cost reduction and scalability for API manufacturers.
Novel route for Gemcitabine HCl with high yield and purity. Reduces steps and improves scalability for API manufacturing.
Patent CN112876524A reveals a scalable, high-yield route for Remdesivir intermediates, offering cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN113880901B reveals a metal-free asymmetric halocyclization route for high-purity nucleoside intermediates, offering significant cost reduction and supply chain reliability.
Efficient rhodium-catalyzed asymmetric cyclopropanation for antiviral drug intermediates. High enantioselectivity and scalable process for pharmaceutical manufacturing.
Patent CN105693627A reveals efficient Ru-pheox catalysis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Novel patent CN113248538B details high-yield Remdesivir synthesis. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Patent CN105693725A reveals efficient asymmetric cycloaddition for high-purity nucleoside analogues, offering supply chain stability and cost reduction in API manufacturing.
Patent CN102127135B reveals a mild gold-catalyzed glycosylation method for nucleoside intermediates, offering superior regioselectivity and cost reduction in pharmaceutical manufacturing.